S. Yasar, J. Xia, and W. Yao, Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study, Neurology, vol.81, pp.896-903, 2013.

Y. F. Chuang, J. C. Breitner, and Y. L. Chiu, Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study, Neurobiol Aging, vol.35, pp.2429-2435, 2014.

K. L. Goh, K. Bhaskaran, C. Minassian, S. J. Evans, L. Smeeth et al., Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink, Br J Clin Pharmacol, vol.79, pp.337-350, 2015.

W. Q. Qiu, M. Mwamburi, and L. M. Besser, Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele, J Alzheimers Dis, vol.37, pp.421-428, 2013.

D. Shimbo, J. D. Newman, and A. K. Aragaki, Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative, Hypertension, vol.60, pp.625-630, 2012.

P. M. Rothwell, S. C. Howard, and E. Dolan, Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension, Lancet, vol.375, pp.895-905, 2010.

M. Nagai, S. Hoshide, J. Ishikawa, K. Shimada, and K. Kario, Visitto-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease, J Hypertens, vol.30, pp.1556-1563, 2012.

B. Sabayan, L. W. Wijsman, and J. C. Foster-dingley, Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study, BMJ, vol.347, p.4600, 2013.

A. Alperovitch, M. Blachier, and A. Soumare, Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study, Alzheimers Dement, vol.10, pp.330-337, 2014.

N. C. Li, A. Lee, and R. A. Whitmer, Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis, BMJ, vol.340, p.5465, 2010.

Z. Guo, L. Fratiglioni, L. Zhu, J. Fastbom, B. Winblad et al., Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use, Arch Neurol, vol.56, pp.991-996, 1999.

M. Morris, P. A. Scherr, L. E. Hebert, R. J. Glynn, D. A. Bennett et al., Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study, Arch Neurol, vol.58, pp.1640-1646, 2001.

E. D. Louis, J. Benito-leon, and F. Bermejo-pareja, Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NE-DICES), Neuroepidemiology, vol.33, pp.286-292, 2009.

. The-3c-study and . Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

P. Brindel, O. Hanon, and J. F. Dartigues, awareness, treatment, and control of hypertension in the elderly: the Three City study, J Hypertens, vol.24, pp.51-58, 2006.

A. Alpérovitch, T. Kurth, and M. Bertrand, Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study, BMJ, vol.350, p.2335, 2015.

M. D. Haag, A. Hofman, P. J. Koudstaal, M. M. Breteler, and B. H. Stricker, Duration of antihypertensive drug use and risk of dementia: a prospective cohort study, Neurology, vol.72, pp.1727-1734, 2009.

, World Health Organization. Guidelines for ATC Classification and DDD Assignment. Oslo: Norwegian Institute of Public Health, 2002.

H. Arima, C. Anderson, and T. Omae, Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial, J Neurol Neurosurg Psychiatry, vol.85, pp.1284-1285, 2014.

H. Lenoir, C. Dufouil, and S. Auriacombe, Depression history, depressive symptoms, and incident dementia: the 3C Study, J Alzheimers Dis, vol.26, pp.27-38, 2011.

, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.

, National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, vol.39, pp.1-266, 2002.

M. Froissart, J. Rossert, C. Jacquot, M. Paillard, and P. Houillier, Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function, J Am Soc Nephrol, vol.16, pp.763-773, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00149221

L. S. Radloff, The CES-D scale: a self-report depression scale for research in the general population, App Psychol Meas, vol.1, pp.385-401, 1977.

S. Gao, H. C. Hendrie, and C. Wang, Redefined blood pressure variability measure and its association with mortality in elderly primary care patients, Hypertension, vol.64, pp.45-52, 2014.

K. J. Rothman, No adjustments are needed for multiple comparisons, Epidemiology, vol.1, pp.43-46, 1990.

J. Tamargo, J. Segura, and L. M. Ruilope, Diuretics in the treatment of hypertension: part 2: loop diuretics and potassiumsparing agents, Expert Opin Pharmacother, vol.15, pp.605-621, 2014.

L. W. Wijsman, A. J. De-craen, and M. Muller, Blood pressure lowering medication, visit-to-visit blood pressure variability, and cognitive function in old age, Am J Hypertens, vol.29, pp.311-318, 2016.

G. E. Crichton, M. F. Elias, G. A. Dore, R. V. Torres, and M. A. Robbins, Measurement-to-measurement blood pressure variability is related to cognitive performance: the Maine Syracuse study, Hypertension, vol.64, pp.1094-1101, 2014.

R. Peters, A. Booth, and J. Peters, A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly, J Hypertens, vol.32, pp.1945-1957, 2014.

D. Paris, C. Bachmeier, and N. Patel, Selective antihypertensive dihydropyridines lower Abeta accumulation by targeting both the production and the clearance of Abeta across the blood-brain barrier, Mol Med, vol.17, pp.149-162, 2011.

F. M. Laferla, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat Rev Neurosci, vol.3, pp.862-872, 2002.

S. Yasar, M. Corrada, R. Brookmeyer, and C. Kawas, Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging, Neurobiol Aging, vol.26, pp.157-163, 2005.

F. Forette, M. L. Seux, and J. A. Staessen, The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study, Arch Intern Med, vol.162, pp.2046-2052, 2002.

S. Yasar, F. M. Lin, and L. P. Fried, Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study, Alzheimers Dement, vol.8, pp.188-195, 2012.

P. J. Tully, O. Hanon, S. Cosh, and C. Tzourio, Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies, J Hypertens, vol.34, pp.1027-1035, 2016.

A. Althaher, A. Al-khateeb, and M. , Relation between uric acid and Alzheimer's disease in elderly Jordanians, J Alzheimers Dis, vol.44, pp.859-865, 2015.

B. Masereel, P. Renard, M. Schynts, B. Pirotte, P. De-tullio et al., Synthesis and pharmacology of pyrid-3-yl sulfonylureas and thioureas as astrocytic Na1 2C12 K1 cotransporter inhibitors, Eur J Med Chem, vol.29, pp.527-535, 1994.

C. Baudelet, R. Demeure, and A. Frois, Evidence for a neuroprotective effect of pyrid-3-yl-sulphonyl-urea in photochemically induced focal ischaemia in rats: magnetic resonance imaging evaluation, J Pharm Pharmacol, vol.51, pp.967-970, 1999.

P. J. Tully, S. Debette, J. F. Dartigues, C. Helmer, S. Artero et al., Antihypertensive drug use, blood pressure variability, and incident stroke risk in older adults: Three-City cohort study, Stroke, vol.47, pp.1194-1200, 2016.